| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.28 | 0.1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |